BINYAMINA, Israel and CARY, N.C., May 23, 2024 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has been accepted for a poster presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, to be held from May 31 to June 4, 2024, in Chicago, Illinois. The presentation will highlight the ability of the company’s PROphet® platform to predict clinical benefit from immune checkpoint inhibitor (ICI)-based therapies across various cancer indications.

Read more here.